Cross-platform evaluation of LLM-generated educational texts on cardiac myxoma: quality, readability, and actionability using network analysis and latent profile analysis - Top-Institutions - MDSpire

Cross-platform evaluation of LLM-generated educational texts on cardiac myxoma: quality, readability, and actionability using network analysis and latent profile analysis

  • By

  • Bo Deng

  • Zhiqiang Wang

  • Tong Cheng

  • Zhiwen Zhang

  • Muwei Li

  • June 10, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    NYU Langone Health
    NYU Langone Health

    New York, NY

    Key Differentiators

    • Cardiology
    • Heart & Vascular Surgery

  • #2

    The Mount Sinai Hospital
    The Mount Sinai Hospital

    New York, NY

    Key Differentiators

    • Cardiology

  • #3

    Charité Berlin
    Charité Berlin

    Berlin, Germany

    Key Differentiators

    • Cardiology

  • #4

    University College Cork Medical School
    University College Cork Medical School

    Cork, Ireland

    Key Differentiators

    • Cardiology

  • #5

    German specialised cardiomyopathy centres
    German specialised cardiomyopathy centres

    Various, Germany

    Key Differentiators

    • Cardiology

Original Source(s)

Cross-platform evaluation of LLM-generated educational texts on cardiac myxoma: quality, readability, and actionability using network analysis and latent profile analysis

  • by Bo Deng, Zhiqiang Wang, Tong Cheng, Zhiwen Zhang, Muwei Li

  • June 10, 2026

Related Content

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.

Children born SGA receiving growth hormone have similarly impaired glucose-insulin metabolism as children with obesity

Breaking the Biomarker Bottlenecks: Part 2

Industry leaders from AstraZeneca, Leica Biosystems, and Danaher share their insights on AI’s power to democratize access to precision medicine

  • February 16, 2026

  • 9 min